Laddar...
Prolonged First-Dose Hypotension Induced by Sacubitril/Valsartan
Entresto was recommanded by major guidelines as the frontline therapy for heart failure with reduced ejection fraction since its clinical benefit was proved by the PARADIGM-HF trial. Angiotensin converting enzyme inhibitors are the cornerstone of the treatment of HF. Varying incidences of first-dose...
Sparad:
| I publikationen: | Acta Cardiol Sin |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Taiwan Society of Cardiology
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5777949/ https://ncbi.nlm.nih.gov/pubmed/29375230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6515/ACS.201801_34(1).20170614A |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|